Oragenics Stock Filter Stocks by Fundamentals
OGEN Stock | USD 1.07 0.02 1.90% |
Oragenics fundamentals help investors to digest information that contributes to Oragenics' financial success or failures. It also enables traders to predict the movement of Oragenics Stock. The fundamental analysis module provides a way to measure Oragenics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oragenics stock.
Oragenics | Shares Owned by Insiders |
Oragenics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Oragenics from analyzing Oragenics' financial statements. These drivers represent accounts that assess Oragenics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Oragenics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 22.1M | 25.4M | 50.4M | 12.7M | 12.7M | 12.0M | |
Enterprise Value | 4.8M | 8.6M | 23.9M | 1.9M | 9.5M | 18.0M |
Oragenics Fundamentals
Return On Equity | -2.55 | ||||
Return On Asset | -1.32 | ||||
Operating Margin | (555.20) % | ||||
Current Valuation | 3.23 M | ||||
Shares Outstanding | 4.48 M | ||||
Shares Owned By Insiders | 23.23 % | ||||
Shares Owned By Institutions | 7.37 % | ||||
Number Of Shares Shorted | 35.61 K | ||||
Price To Earning | (2.28) X | ||||
Price To Book | 3.50 X | ||||
Price To Sales | 146.37 X | ||||
Revenue | 37.65 K | ||||
Gross Profit | (9.94 M) | ||||
EBITDA | (10.64 M) | ||||
Net Income | (20.66 M) | ||||
Cash And Equivalents | 17.87 M | ||||
Cash Per Share | 0.15 X | ||||
Total Debt | 322.51 K | ||||
Debt To Equity | 0.02 % | ||||
Current Ratio | 12.31 X | ||||
Book Value Per Share | 0.51 X | ||||
Cash Flow From Operations | (7.29 M) | ||||
Short Ratio | 0.55 X | ||||
Earnings Per Share | (9.18) X | ||||
Target Price | 90.0 | ||||
Beta | 0.32 | ||||
Market Capitalization | 4.79 M | ||||
Total Asset | 4.97 M | ||||
Retained Earnings | (206.22 M) | ||||
Working Capital | 12.69 M | ||||
Current Asset | 5.64 M | ||||
Current Liabilities | 1.05 M | ||||
Net Asset | 4.97 M |
About Oragenics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oragenics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oragenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oragenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Oragenics Piotroski F Score and Oragenics Altman Z Score analysis. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.Note that the Oragenics information on this page should be used as a complementary analysis to other Oragenics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Oragenics Stock analysis
When running Oragenics' price analysis, check to measure Oragenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oragenics is operating at the current time. Most of Oragenics' value examination focuses on studying past and present price action to predict the probability of Oragenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oragenics' price. Additionally, you may evaluate how the addition of Oragenics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Oragenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.18) | Revenue Per Share 0.017 | Quarterly Revenue Growth (0.91) | Return On Assets (1.32) | Return On Equity (2.55) |
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.